logo

For the Inventor, By the Inventor

Nogi, Japan

Shizuyoshi Fujimori

This inventor holds 8 USPTO granted patents. Top assignee: Kyorin Pharmaceutical Co., Ltd.. Active years: 1986-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shizuyoshi Fujimori. Retrieved from https://idiyas.com/inventor/shizuyoshi-fujimori

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8

% Patents Active = 87.5

Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 51(Granted Patents)


Location History:

  • Tochigi, JP (1988)
  • Ooaza-Marubayashi, JP (1990)
  • Marubayashi, JP (1993)
  • Nogi, JP (1986 - 1994)
  • Nogi-machi, JP (2003)

Company Filing History:

goldMedal8 out of 185 
 
Kyorin Pharmaceutical Co., Ltd.
 patents

Years Active: 1986-2003

Loading Chart...
8 patents (USPTO):Explore Patents
1. 6545026 - Substituted benzylthiazolidine-2,4-dione derivatives (2003-04-08),
2. 5281600 - Cyclic anthranilic acid derivatives (1994-01-25),
3. 5234928 - Quinazoline-3-alkanoic acid derivatives, their salts and their (1993-08-10),
4. 5147874 - Cyclic anthranilic acid derivatives and process for their preparation (1992-09-15),
5. 4956372 - Cyclic anthranilic acid derivatives and process for their preparation (1990-09-11),
6. 4764608 - Process for the manufacture of spiro-linked pyrrolidine-2,5-dione (1988-08-16),
7. 4749789 - Process for the manufacture of spiro-linked pyrrolidine 2,5-diones (1988-06-07),
8. 4593092 - Class of spiro-linked pyrrolidine-2,5-diones (1986-06-03),

Title: Shizuyoshi Fujimori: Innovator in Pharmaceutical Chemistry

Introduction

Shizuyoshi Fujimori is a notable inventor based in Nogi, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 8 patents. His work focuses on innovative compounds that have potential therapeutic applications.

Latest Patents

Fujimori's latest patents include the development of substituted benzylthiazolidine-2,4-dione derivatives and cyclic anthranilic acid derivatives. One of his notable inventions is an antirheumatoid pharmaceutical composition that contains a cyclic anthranilic acid derivative. This composition features a complex formula where various groups can be substituted, indicating a high level of specificity and potential efficacy in treating rheumatoid conditions.

Career Highlights

Fujimori is currently associated with Kyorin Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has been instrumental in creating new pharmaceutical solutions that address various health issues.

Collaborations

Fujimori has collaborated with esteemed colleagues such as Eisuke Kojima and Katsuya Awano. These partnerships have fostered a collaborative environment that enhances innovation and the development of new pharmaceutical products.

Conclusion

Shizuyoshi Fujimori's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His ongoing work promises to lead to significant advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…